Cefuroxime Sodium EP Impurity F
97170-19-9
100MG
2022-03-31
Nexium,Cefuroxim impurities
-
Product Description
-
Seller Information
-
DescriptionBasic Info
-
Product Name:
(6R,7R)-7-[[(2E)-2-(2-Furanyl)-2-(methoxyimino)acetyl]amino]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Other Name:5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2E)-2-(2-furanyl)-2-(methoxyimino)acetyl]amino]-3-(hydroxymethyl)-8-oxo-,(6R,7R)-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[2-furanyl(methoxyimino)acetyl]amino]-3-(hydroxymethyl)-8-oxo-,[6R-[6α,7β(E)]]-;(6R,7R)-7-[[(2E)-2-(2-Furanyl)-2-(methoxyimino)acetyl]amino]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
CAS No.:97170-19-9
Molecular Formula:C15H15N3O7S
InChIKeys:InChIKey=OUSLHGWWWMRAIG-OGAOBHAHSA-N
Molecular Weight:381.4
Exact Mass:381.36
EC Number:260-086-2
UNII:P7563XP7TW
Categories:
Characteristics -
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Nexium,Cefuroxim impurities
-
Location:
A06-07, Shengboya Business Center, Sanlian Road, Longhua Street, Longhua District, Shenzhen
-
Payment Terms:
D/P
-
Average lead Time:
30
-
Total Annual Revenue:
$5 million-$10 million
-
Year of Establishment:
2014
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product